Tradercommunity Clickoptions Forum

[Newsagent]

PR inside: CNS Pharmaceuticals Participates in Virtual Investor CEO Connect Segment ...

(PR-inside.com) HOUSTON, TX / ACCESS Newswire / July 9, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that John Climaco, CEO of CNS Pharmaceuticals recently participated in a Virtual Investor CEO Connect segment.

As part of this segment, Mr. Climaco provided an overview of CNSP's lead program, TPI 287, and discussed key insights from his recent attendance at the Longwood Healthcare Leaders Spring 2025 Meeting in Cambridge, MA.

The Virtual Investor CEO Connect featuring CNS Pharma is ..

https://reports.pr-inside.com/cns-pharm ... 118547.htm
Copyright PR-Inside.com 2025